✦ LIBER ✦

Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis

✍ Scribed by Moshe Talpaz; Razelle Kurzrock; Hagop Kantarjian; Susan O'Brien; Jordan U. Gutterman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon alpha-2b as treatment for Phi

✍ M. Lazzarino; A. Vitale; E. Morra; A. Gagliardi; P. Bernasconi; C. Torromeo; D. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB

Treatment of thrombocytosis in myeloprol

✍ Tichelli, A. ;Gratwohl, A. ;Berger, C. ;Lori, A. ;W�rsch, A. ;Dieterle, A. ;Thom 📂 Article 📅 1989 🏛 Springer-Verlag ⚖ 449 KB

Alpha interferon treatment of essential

✍ Xenophon Yataganas; John Meletis; Eleni Plata; Nora Viniou; Filippos Deligiannis 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 346 KB

O40 Results of the interferon-alpha 2b t

✍ M.A. Sokolova; N.D. Khoroshko; N.V. Tsvetaeva; M.D. Sanatko; A.V. Misurin; V.V. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

The JAK2 V617F mutation involves B- and

✍ Thomas Stauffer Larsen; Jacob Haaber Christensen; Hans Carl Hasselbalch; Niels P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

The impact of JAK2 non-receptor tyrosine

✍ Supattra Kannim; Chirayu U. Auewarakul 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 97 KB 👁 2 views